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SUMMARY
The biological membranes of Trypanosoma brucei contain a complex array of phospholipids that are synthesized de novo
from precursors obtained either directly from the host, or as catabolised endocytosed lipids. This paper describes the use
of nanoﬂow electrospray tandem mass spectrometry and high resolution mass spectrometry in both positive and negative
ion modes, allowing the identiﬁcation of 500 individual molecular phospholipids species from total lipid extracts
of cultured bloodstream and procyclic form T. brucei. Various molecular species of all of the major subclasses of
glycerophospholipids were identiﬁed including phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and
phosphatidylinositol as well as phosphatidic acid, phosphatidylglycerol and cardolipin, and the sphingolipids sphingo-
myelin, inositol phosphoceramide and ethanolamine phosphoceramide. The lipidomic data obtained in this study will aid
future biochemical phenotyping of either genetically or chemically manipulated commonly used bloodstream and procyclic
strains of Trypanosoma brucei. Hopefully this will allow a greater understanding of the bizarre world of lipids in this
important human pathogen.
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INTRODUCTION
Phospholipids (PLs) are vital and ubiquitous
components of the cell membrane bilayer that delin-
eates the conﬁnes of a cell and its subcellular compart-
ments. The major classes of glycerophospholipids
include: phosphatidic acid (PA), phosphatidyl-
glycerol (PG), phosphatidylinositol (PI), cardiolipin
(CL) and the aminoglycerophospholipids: phospha-
tidylcholine (PC), phosphatidylethanolamine (PE)
and phosphatidylserine (PS) (Fahy et al. 2005).
Considering that their hydrophobic chains can vary
in length and degree of unsaturation, a wide variety of
diﬀerent molecular species of each phospholipid class
are possible. This diversity allows the formation of
highly specialised membranes with unique functions;
also the alteration of the membrane lipid composition
allows the cell to respond to environmental changes.
The glycerophospholipid composition of membranes
varies with cell type in multicellular organisms, and
is diﬀerent in the individual organelles in eukaryotic
cells. The composition also depends on growth con-
ditions, such as pH, temperature and the growth
phase; lipids are also not equally distributed across
the two leaﬂets of a membrane bilayer (Zachowski,
1993). Furthermore, in higher eukaryotes bioactive
precursors stored in PLs and released by phospho-
lipases have been recognized as important factors in
signal transduction and in the generation of lipid
mediators, such as eicosanoids (James and Downes,
1997; Six and Dennis, 2000). Phospholipase-
modiﬁed PLs are themselves important mediators
in cellular processes such as apoptosis and membrane
traﬃcking (Fadok et al. 2001; Ishii et al. 2004).
Trypanosoma brucei, the causative agent of African
sleeping sickness, belongs to the order Kineto-
plastida, which are considered part of the earliest
diverging eukaryotic lineages (Michels et al. 2000).
As such, there is an historical precedence to regard
T. brucei as a ‘model organism’ for the study of
alternative mechanisms by which eukaryotes ac-
complish basic functions (Michels et al. 2000).
During their life-cycle they encounter vastly diﬀerent
environments and respond to these by dramatic mor-
phological and metabolic changes, including adap-
tation of their lipid and energy metabolism (Michels
et al. 2000). Lipids constitute 11–18% of the dry
weight ofT. brucei and their distribution is consistent
with the usual range of lipids found in eukaryotes,
such as phospholipids, neutral lipids, sterols, fatty
acids, plasmalogens, isoprenoids and sterols (Dixon
andWilliamson, 1970; Dixon et al. 1971; Venkatesan
and Ormerod, 1976; Patnaik et al. 1993; Smith, 1993;
Vial et al. 2003).
T. brucei contains all the major phospholipid
classes, accounting for 80% of membrane lipids† These authors contributed equally.
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(Patnaik et al. 1993). Trypanosomes do not utilise the
intact phospholipids they scavenge from their hosts,
but use their repertoire of metabolic and anabolic
enzymes to synthesise their own phospholipids and
glycolipids de novo as per their speciﬁc requirements
(Dixon and Williamson, 1970; van Hellemond and
Tielens, 2006). Until relatively recently most of the
literature on T. brucei lipid metabolism involved
myristate metabolism and its requirement for glyco-
sylphosphatidylinositol (GPI) anchor biosynthesis
(Buxbaum et al. 1994, 1996). With the completion of
the T. brucei genome, several biosynthetic enzymes
involved in de novo synthesis of phospholipids have
been studied, including: sphingomyelin synthases, a
phospholipase A1, the phosphatidylinositol synthase
and enzymes of the Kennedy pathway involved in
de novo PE and PC synthesis – this has been reviewed
recently (Smith and Bütikofer, 2010).
Since many pathogens have developed unique
membrane structures and specialised lipid biosyn-
thetic pathways that diﬀer from those of the host, the
study of lipid metabolism could unravel novel drug
targets for therapeutic intervention. As progress in
research elucidates lipid metabolism in greater detail
in parasites and hosts, and more enzymes involved
in phospholipid metabolism are characterized, new
targets are likely to emerge for the development of
new anti-protozoan drugs. For example, it has been
shown that a possible mechanism of action of the
lysophospholipid analogues, miltefosine, edelfosine
and ilmofosine, against Leishmania andTrypanosoma
cruzi proceeds through the inhibition of PC biosyn-
thesis (Urbina, 2006). Bisthiazolium compounds are
choline analogues showing strong potency against the
malaria parasite Plasmodium falciparum and they
were shown to target PC biosynthesis from choline
and ethanolamine (Le Roch et al. 2008).
In trypanosomes, aswith other cells, oldermethods
of PL analysis relied heavily upon thin layer chro-
matography to separate and identify various PL
classes. Subsequently gas chromatography was em-
ployed to analyze the overall fatty acid composition
(Godfrey, 1967; Dixon andWilliamson, 1970). Later
some T. brucei PL molecular species were identiﬁed
by benzoyl derivatisation of the diradylglycerols
derivatives followed by thin layer chromatography
separation of diacyl, alkylacyl and alkenylacyl frac-
tions prior to reverse phase chromatography/mass
spectrometry (Patnaik et al. 1993). These older
methods are time, labour and material expensive,
which makes these multi-step analyses vulnerable
to oxidation and other modiﬁcations during prep-
aration. Although not used to study T. brucei lipid
composition, fast atom bombardment MS has alle-
viated many of these disadvantages and allowed
sensitive analysis of intact lipids (Chilton and
Murphy, 1986). The next generation of MS tech-
nology, electrospray ionization tandem mass spec-
trometry (ESI-MS-MS), allows ‘soft’ ionization of
biomolecules without chromatographic separation or
derivatization, and has the beneﬁt of high sensitivity
and reproducibility (Kerwin et al. 1994;Brugger et al.
1997). ESI-MS-MS allows speciﬁc detection of the
major PL classes and subclasses, and their molecular
species, from the same sample. Thismethodology has
proved an eﬃcient tool for examining alterations in
the cell’s lipidome after cellular perturbations, either
genetically or chemically. For instance, it has been
used to analyze global changes in the PL content of
sphingomyelin-deﬁcient and alkylacyl/alkenylacyl
PL-deﬁcient Leishmania major (Zuﬀerey et al. 2003;
Denny et al. 2004), and knock-outs or knock-downs
of enzymes involved directly or indirectly in de novo
lipid synthesis in T. brucei (Voncken et al. 2003;
Martin and Smith 2006a,b; Richmond and Smith
2007a,b; Güler et al. 2008; Signorell et al. 2008;
Gibellini et al. 2009 and reviewed in van Hellemond
and Tielens, 2006).
Here we report the lipidomes of commonly used
laboratory strains BSF and PCF T. brucei, charac-
terizing 500 individual molecular phospholipid
species. This will provide a useful tool to the com-
munity to aid future biochemical phenotyping of
either genetically or chemically altered T. brucei.
MATERIALS AND METHODS
Materials
All solvents were analytical HPLC grade and from
BDH. Glassware was used at all times after the
introduction of solvent to the samples, except when
loading samples into nanoﬂow tips. Glassware was
solvent washed and positive displacement pipettes
with glass tips were used to measure solvent quan-
tities, where possible. Ethanol-1,1,2,2-d4-amine
(d4-ethanolamine) were from CDN Isotopes. The
non-natural phospholipid standards 1,2-dihepta-
decanoyl-sn-glycero-3-phosphate, PA (17:0/17:0);
1,2- dipentadecanoyl-sn-glycerol-3-phosphoethanol-
amine PE (15:0/15:0); 1,2-dimyristoyl-sn-glycero-
3-[phospho-rac-(1-glycerol)], PG (14:0/14:0);
1,2-diheneicosanoyl-sn-glycero-3-phosphocholine,
PC (21:0/21:0); 1,2-dimyristoyl-sn-glycerol-3-
[phospho-L-serine], PS (14:0/14:0); 1-dodecanoyl-
2-tridecanoyl-sn-glycero-3-phospho-(1′-myo-inositol),
PI (12:0/13:0); and 1,2 dipalmitoyl-sn-glycerol,
DAG (16:0/16:0), were purchased from Avanti
Polar Lipids.
T. brucei cell culture
Bloodstream form (BSF) trypanosome cultures
(strain 427, MITat 1.2) were maintained in HMI-9
media at pH 7·5, supplemented with 10% heat-
inactivated foetal calf serum (PAA Labs) and 10%
Serum Plus (JRH Biosciences). Cells were grown
in Cell star tissue culture ﬂasks with air ﬁlter lids
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(Greiner) and incubated in a humidiﬁed 37 °C in-
cubator with 5% CO2. The BSF in vitro culture cell
line used throughout this study is from the long-term
cultures of ‘single marker’ cells that express a tetra-
cycline repressor and T7 RNA Polymerase (Wirtz
et al. 1999). This transgenic parental cell line was
maintained under neomycin (G418) drug pressure
at a ﬁnal concentration of 2·5 μg/ml. Cultures
were normally maintained below a cell density of
2×106/ml before lipid extraction. Procyclic form
(PCF) trypanosome cultures were maintained in
supplemented SDM-79 media at pH 7·4 which
contained 15% heat-inactivated foetal calf serum as a
lipid source, 2 g/L NaHCO3, 2·5 mg/ml haemin and
1x Glutamax (Invitrogen). Cells were grown in non-
tissue culture treated ﬂasks (Falcon) in a humidiﬁed
28 °C incubator with 5% CO2. The PCF in vitro
culture cell line used throughout these studies is from
the long-term cultures of ‘double marker’ cells that
express a tetracycline repressor and T7 RNA poly-
merase. This transgenic parental cell line was main-
tained under neomycin (G418) and hygromycin
drug pressure at ﬁnal concentrations of 15 μg/ml and
50 μg/ml, respectively. Cultures were normally main-
tained below a cell density of 2×107/ml before lipid
extraction.
Lipid extraction
Lipids were extracted according to the method of
Bligh and Dyer (Bligh and Dyer, 1959). To detect
minor mass constituents a relatively high concen-
tration of cells was used; when better resolution
between individual molecular species peaks was
desired, the sample was diluted with more solvent.
Normally, 108 cells were harvested, washed twice in
TDB, (25mM KCl, 400mM NaCl, 5 mM MgSO4,
100mM Na2HPO4, NaH2PO4, 100mM glucose) and
resuspended in 100 μl TDB in a glass vial prior to
lipid extraction. A mixture of the internal standards
(50 pmoles of each, except PI which was 20 pmoles)
was added prior to removal of the lower cholorform
rich phase. This allowed normalization of the data
obtained from the high-resolutionmass spectra and to
ensure correct fragmentation of individual phospho-
lipids species.
The lipid-rich lower phase was washed by mixing
it with 225 μl of upper phase from a blank sample.
The resultant lower phase was transferred to a new
vial and dried under nitrogen. The lipids were re-
suspended with chloroform/methanol (1:2 v/v) to the
desired volume (10–40 μl), just prior to ESI-MS-MS
analysis. The vials were centrifuged at 5000×g for
1 min. Samples were usually processed and analyzed
the same day, but if short-term storage was necessary
the lipids were stored dried under a nitrogen atmos-
phere at 4 °C.
High-resolution mass spectrometry
An aliquot of the total lipid extract was analyzed with
both an electrospray ionisation mass spectrometer
(LCT, Micromass) and a QStar mass spectrometer
(Applied Biosystems) both equipped with nanoelec-
trospray sources. Samples were loaded into thin-wall
nanoﬂow capillary tips (Waters) and analyzed in both
positive and negative ion mode.
Each spectrum encompasses at least 50 repetitive
scans (400–2000m/z). Spectra were processed using
Micromass software; a high-resolution peak list was
generated and normalized to the masses of the non-
natural internal standards. Isotope ions were elim-
inated, i.e. due to naturally occurring 13C (1·1%). The
resulting high-resolution data were normalized using
the internal standards. These data have been anno-
tated to the corresponding phospholipid species
in Supplementary Tables 1–8 (see Appendix), the
accurate masses correspond to the mean (±0·05 m/z)
of 4 separate determinations using the two diﬀerent
instruments.
Nano-electrospray ionization tandem mass
spectrometry (nano-ESI-MS-MS)
An aliquot of total lipid extract was analyzed with
a Micromass Quattro Ultima triple quadrupole
mass spectrometer equipped with a nanoelectrospray
source. Samples were loaded into thin-wall nanoﬂow
capillary tips (Waters) and analyzed by ESI-MS-
MS in both positive (for phosphatidylcholine (PC),
sphingomyelin (SM), phosphatidylserine (PS) and
phosphatidylethanolamine (PE)), and negative ion
mode (for PI, phosphatidylglycerol (PG), phospha-
tidic acid (PA), PS and PE). Capillary/cone voltages
were 0·7 kV/50 V and 0·9 kV/50 V for positive ion
and negative ion modes, respectively. Tandem mass
spectra (MS-MS) were obtained using argon as the
collision gas (3·0 mTorr) with collision oﬀset
energies as follows: 35 V, PC in positive ion mode;
25 V, PE in positive ion mode; 22 V, PS in positive
ion mode; 50 V, PE in negative ion mode; 28 V, PS in
negative ion mode; 45 V, PI in negative ion mode;
and 50 V, all glycerophospholipids detected by pre-
cursor scanning for m/z 153 in negative ion mode.
MS-MS daughter ion scanning was performed with a
collision-oﬀset energy of 35 V. In positive ion mode,
ions in the PC, PE, and PS spectra were annotated
based on their [M+H-NMe3]
+ for PC, and the
corresponding fragment ions [M-140] and [PA-H]
daughter ions for PE and PS respectively, and com-
pared with that of their theoretical values. In negative
ion mode, PL class peaks were assigned according
to their [lyso-H]−, [lyso-H20-H]
−, [lysoPA-H]−, or
[lysoPA-H20-H]
− daughter ion derivatives. FAs
were assigned based on their [M−H]− values.
Saturated and unsaturated FAs were assumed to be
esteriﬁed to the sn-1 and sn-2 position of PLs,
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respectively. Each spectrum (600–1000m/z) encom-
passes at least 50 repetitive scans, each of 4 s duration.
Spectra were normally processed by subtraction of
background and smoothed using Micronass pro-
cessing algorithms unless otherwise indicated. The
internal standards were used to ensure eﬃcient ion-
ization and fragmentation and as a control for sample
variability.
Stable isotope labeling of bloodstream form T. brucei
2·5×107 T. brucei bloodstream-form cells at a den-
sity of 0·5×106 cells/ml were incubated overnight
at 37 °C in HMI-9 media supplemented with 1mM
d4-Etn. Total lipids were extracted and processed
using a nano-ESI-MS-MS as described earlier. [M−
H]− adducts of unlabelled PE and (d4)-labelled
PE were monitored by parent ion scanning for m/z
196 and 200, respectively. [M+H]+ adducts of un-
labelled PC and (d4)-labelled PC were monitored
by parent ion scanning for m/z 184 and 188,
respectively.
RESULTS AND DISCUSSION
Phospholipid composition
Quantiﬁcation of the phospholipids in blood-
stream and procyclic T. brucei shows the most
abundant glycerophospholipid classes are PC and
PE representing 45–60% and 10–20%, while PI, PS,
PG and CL represent minor glycerophospholipid
classes (Fig. 1). These values compare well with
previous quantiﬁcations of phospholipids inT. brucei
(Patnaik et al. 1993). T. brucei also contain sphingo-
lipids, such as sphingomyelin (SM), inositol
phosphorylceramide (IPC) and ethanolamine phos-
phorylceramide (10–15% in total).
High-resolution mass spectra were collected both
in positive and negative ion mode for BSF and
PCF T.brucei total lipid extracts (Figs 2 and Fig. 3,
respectively). In the positive ion mode, ions rep-
resents [M+H]+ and [M+Na]+ of PC, SM and to a
minor extent PE and PS species, while in the nega-
tive ionmode, ions represent [M−H]− of PI, PE, PS,
PG and PA species. Peak lists from these data were
normalized using the added non-natural internal
standards. After averaging, these data were used to
clarify some of the phospholipid identities given in
Tables S1–S8 (see Appendix). ESI-MS-MS was also
employed to separate and characterize the major PL
classes and their molecular species from total lipid
extracts of T. brucei. Together these two sets of data
allow the identity of 500 individual molecular
phospholipid species to be determined.
Fatty acid composition of PL
Analysis of the acyl content of the various phospho-
lipids suggests that the intrinsic acyl-CoA speciﬁcity
of the acyltransferases involved in diacyl and ether-
linked phospholipid de novo synthesis and the avail-
ability of de novo synthesised acyl-CoAs are major
factors in producing the ﬁnal molecular composition
of the phospholipids species. The major ether-linked
PE and PC species and the diacyl linked PC, PE,
PI and PS species contain almost exclusively sn-1
C18:0. This implies both the acyltransferases that
service dihydroxyacetone-phosphate and glycerol-
3-phosphate have either a speciﬁcity for C18:0-CoA
or are exposed exclusively to C18:0-CoA. The sn-2
position of these lipid species are almost exclusively
unsaturated acyl groups, with ether-linked lipids
Fig. 1. Phospholipid composition of PCF and BSF T. brucei. PC, phosphatidylcholine; PE, phosphatidylethanolamine;
PI, phosphatidylinositol; PS, phosphatidylserine; SM, sphingomyelin. “Others” include: inositol phosphoceramide,
phosphatidic acid, phosphatidylglycerol, cardiolipin, PIPs, lyso-PC and lyso-PE.
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containing predominately C18:2, while diacyl lipids
contain mainly C18:2 and C22:4, with minor C20:4.
In T. brucei procyclic forms, the relative amounts
of diacyl glycerophospholipids containing highly
unsaturated fatty acyl chains showed a decrease
compared to bloodstream forms, in the order of PC
>PE>>PI. T. brucei parasites also contain signiﬁ-
cant proportions of sn-1 ether-linked glycero-
phospholipids, especially in PE (73–84%) and PS
(60–88%).
Choline PL composition
In positive ion mode, [M+H]+ ions of PC and SM
are detected by colliding ions with argon to create
various fragment ions and, in the case of choline-
containing PLs like PC and SM, an intense m/z 184
fragment is produced. Thus, a positive ion precursor
scan form/z 184 detects all PC and SM [M+H]+ ions
and their natural isotopes, each represented as a m/z
signal in a spectrum. Colliding ions from the mono-
isotopic signals produces speciﬁc daughter ion frag-
ments which are used to correctly assign the m/z
signal to a molecular species that contains a certain
number of FA carbons and which have an associated
degree of unsaturation. In positive ion mode,
individual FAs cannot be discerned and thus the
FAmoiety is represented as a sum of FAs in the form
x:y, where ‘x’ is the total number of FA carbons
and ‘y’ is total number of double bonds in both FA
chains. As portrayed in this report, a peak in the
spectrum consists of a series of molecular species of
a particular class of PL with the same number of
carbon atoms, but with diﬀerent masses due to
heterogeneity in their state of unsaturation.
The pool of PC and SM lipids in both PCF
and BSF lipid extracts of T. brucei is comprised
of numerous molecular species (Fig. S1 A and B,
respectively, see Appendix). Annotation of these
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Fig. 2. High resolution survey scans in positive (A) and negative (B) ion mode of total lipid extracts from BSF T. brucei.
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species is provided in Tables S1 and S2, respectively.
Analysis of the ions in the spectra (Fig. 4) revealed
that the T. brucei PC pool contains molecular species
from both the diacyl and ether PL subclasses. The
ratio between diacyl and ether PC in both PCF and
BSF cells was roughly 3:1. These subclasses of
phospholipids in T. brucei, as with other eukaryotes,
are deﬁned by their sn-1 fatty acyl bond and are
referred to as either one of the following types: (1)
diacyl; (2) plasmanyl (a, alkylacyl); or (3) plasmenyl/
plasmalogen (e.g. alkenylacyl). It is important to note
that, in both life cycle stages, for nearly every diacyl
PC series there appears to be an alkylacyl/alkenylacyl
PC counterpart. These results contrast with those
from a previous study, which reported that the only
ether-linked PC species in BSF T. brucei was PC
(e/a-36:2 – reported as e/a-18:0/18:2, Patnaik et al.
1993). PC (e/a-18:/18:2) is indeed the most abundant
ether PC in BSF trypanosomes, but heterogeneity
does exist since e/a-PC with other FA chain lengths
were detected. A drawback to identifying PLs by
ESI-MS-MS is that it is not possible to diﬀerentiate
between alkyl and alkenyl sn-1 linkages in many
instances without their prior chromatographic
separation. For instance, an ether-linked a-18:1 and
a vinyl ether-linked e-18:0 possess equivalent masses.
For the m/z 822 PC species in Table S1 (see
Appendix), for example, the presence of sn-2 22:4
with ether-linked e/a-18:y could therefore indicate
the existence of two species with identical masses, PC
(a-18:1/22:4) and/or PC (e-18:0/22:4).
Relative molar composition of PC molecular
species was calculated by integrating the relative
area of the peaks of each series. Such percent
composition analysis showed that, in BSF trypano-
somes for instance, the four main series in the PC
spectrum comprised 34·4%, 19·1%, 13·6%, and 13·0%
of total PC in the cell, and they originated from
signals in the 40:y, 36:y, 38:y, and e/a-36:y series,
respectively (Fig. 4, Table S2, Appendix). Themajor
peak areas from these series are mostly comprised of
the following species of PC: m/z 834, 40:6; m/z 836,
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Fig. 3. High resolution survey scans in positive (A) and negative (B) ion mode of total lipid extracts from PCF T. brucei.
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40:5;m/z 838, 40:4;m/z 786, 36:2;m/z 788, 36:1;m/z
790, 36:0;m/z 810, 38:4;m/z 812, 38:3;m/z 814, 38:2;
m/z 774, a-36:1 and/or e-36:0;m/z 772, a-36:2 and/or
e-36:1. Analysis of the spectra also revealed that
T. brucei possesses PC (42:y) and PC (44:y), unusual
species that most likely contain long-chain poly-
unsaturated FAs (PUFAs) and highly unsaturated
FAs (HUFAs) at the both the sn-1 and sn-2 positions
(Fig. S4, peaks N and O). The most abundant
PUFAs and HUFAs in T. brucei, whose combi-
nations could mostly satisfy the FA requirements in
PC (42:y) and PC (44:y), are 22:4, 22:5, 22:6, 20:2,
20:3, 20:4, and 20:5 (Fig. 4). It is also possible that
the FA 24:1 may be a constituent of these species as
this FA has been reported to exist in PLs of T. brucei
[20]. PC (42:y) and PC (44:y) have not been detected
before in T. brucei but they have been noted in
another kinetoplastid, Leishmania major (Zuﬀerey
et al. 2003; Denny et al. 2004).
Comparisons of the PC proﬁle from PCF and BSF
total lipid extracts (Fig. 4) showed that there were
minor alterations in the prominence of FA unsatu-
ration states in some series. For instance, analysis
from a multitude of runs (>8) showed that the PC
(40:6) signal in PCF cells was consistently more
intense than the PC (40:5) signal, whereas in BSF
Fig. 4. Molecular composition of choline-containing PLs in T. brucei. Precursor ion scanning for m/z 184 speciﬁcally
detected [M+H]+ PC and SM ions from PCF and BSF trypanosome total lipid extracts see Figs. S1 and S2. Molecular
species are plotted against their relative percentage based upon TIC, PCF (BLACK) and BSF (GREY). Peak
assignments are based on MS-MS daughter ion spectra performed as stated in the Material and Methods, and each peak
is annotated in Tables S1 and S2.
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cells the situation is reversed (see Figs 4, S4A and B,
and compare Tables S1 and S2, Appendix). A similar
pattern was observed for the PC (44:n) species.
It is noteworthy that the relative amounts of SM in
PCF cells is signiﬁcantly lower compared to the SM
levels in BSF cells (Figs 1 and 4). This is observed by
comparing peaks C, E, and G in the BSF and PCF
spectra (Figs S4A and B, respectively Appendix).
This is due in part to the ceramide which is normally
used in conjunction with PC to form SM, by the
sphingomyelin synthases, is now also being used to
form inositol phosphoceramide (IPC) from PI in
PCF trypanosomes (Fridburg et al. 2008; Sutterwala
et al. 2008).
Another PL component in T. brucei membranes is
lyso-PC, which is synthesized from the action of a
novel phospholipase A1 in this organism (Richmond
and Smith, 2007a,b). Detection of lyso-PC was
achieved only after restricting the scanned mass
range in the 184m/z precursor ion scans to exclude
the mass range in which the major PC ions fall
(Fig. S2). Analysis of the lyso-PC spectra revealed
distinct lyso-PC species (Fig. 4); the most abundant
species contain one of the following sn-2 FA con-
stituents: 18:0, 18:1, 18:2, 20:2, 20:3, 20:4, 22:4, 22:5
and 22:6. The levels of lyso-PC are higher in BSF
than in PCF trypanosomes. Also, PCF cells appeared
to contain more lyso-PC (-/22:6), whereas the major
BSF lyso-PC species was (-/22:5).
PE composition
In negative ion mode, ions of PI, PA, PG, PS and PE
species are eﬃciently detected. Collision-induced
dissociation of PLs containing an ethanolamine-
phosphate head group produces a unique fragment
ion of m/z 196, and precursor scanning for this ion
from total lipids extracted from PCF and BSF cells
selectively detected [M−H]− ions of PE (Figs S6A
and B, annotated species in Tables S3 and S4,
respectively). The striking feature about this class of
phospholipid is the dominating presence of the
ether PE series e/a-36:y (Fig. 5). The principal signal
within this series speciﬁcally represents the m/z
726 [M−H− ion (Figs S6A and B, Appendix).
From daughter ion scanning the species was deduced
to be PE (e-18:1/18:2) instead of either PE (a-18:0/
18:3) or PE (a-18:1/18:2); this result is consistent
with the previous ﬁnding that there is 2–4 times as
much alkenylacyl PE than alkylacyl PE in T. brucei
(Patnaik et al. 1993). As with PC, it was originally
reported that 100% of all the alkylacyl and alkenylacyl
PE in BSF T. brucei was from just one molecular
species, PE (e/a-18:0/18:2), which is certainly by far
the major species. However, daughter ion scanning of
the PE spectra ions from the ESI-MS-MS method
revealed multiple ether lipid species in both the PCF
and BSF parasite stages (Fig. 5 and annotated in
Tables S3 and S4 respectively).
The relative abundance of diacyl PE in BSF cells is
slightly higher than in PCF cells (36% vs. 19%,
respectively). This is most likely due to the increased
availability of host PUFA resulting in PE species
with longer acyl chains, particularly the 40:y and 42:y
series (Fig. 5).
PE can also be detected in positive ion mode by
scanning for the neutral loss ofm/z 141.However, the
results from negative mode give more accurate
reﬂections of the true abundances of ether PE series
(Brugger et al. 1997). This is also true for T. brucei
where ether PE species in PCF and BSF parasites
make up 81% and 64% of total PE in the cell, re-
spectively; these values correlate well with those
obtained previously (Patnaik et al. 1993). However,
in positive ion mode, the m/z 141 neutral loss scans
show the combined relative abundances of all the
diacyl species (>87%) far exceeded that of all the
ether lipid species (data not shown), thus giving
an inaccurate reﬂection of the true PE status of a
T. brucei cell, and conﬁrming that analyzing PE in
negative ion mode is preferable.
PE cannot be converted into PC in T. brucei
PC and PE are the two major phospholipid classes
in eukaryotic cells and their metabolism is highly
interconnected. They are both synthesised de novo
through branches of theKennedy pathway (Kennedy
and Weiss, 1956; Kanfer and Kennedy, 1963; re-
cently reviewed in Gibellini and Smith, 2010). PE
can also be converted into PC by three subsequent
SAM dependent methylations of the ethanolamine
headgroup. However, in T. brucei the methyl-
transferase genes could not be found (http://www.
tritrypdb.org). This surprising absence of PE
methylation was experimentally conﬁrmed by stable
isotope labelling of bloodstream-form T. brucei with
the PE precursor d4-ethanolamine followed by
analysis of PE and PC molecular species by ESI-
MS/MS (Fig. 6).
PE and PC that incorporate the deuterium-labelled
ethanolamine can be easily distinguished from their
non-labelled counterparts because they produce
fragments at higher m/z: 200m/z for the deuterated
ethanolamine-phosphate-glycerol-H2O instead of
196m/z and 188m/z for the deuterated phospho-
choline instead of 184m/z in positive ion mode
(Figs 6 A–D respectively).
The d4-ethanolamine is readily taken up by the
parasite by an as yet unknown transporter, and in-
corporated into d4-PE, and its molecular species
proﬁle is virtually super-imposable with the one of
the unlabelled PE (Fig. 6A and B). However, the
complete absence of d4-PC species (Fig. 6D), demon-
strates that there is no conversion of d4-PE to d4-PC.
The spectrum including the cellular species of PC
is shown in Fig. 6C as a comparison. This indicates
that there is no methylation of PE under these
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conditions, thus all T. brucei choline is scavenged
from its host, and thus they are auxotropic for
choline. Given the fact that they can not take up
choline, as they do not process a choline transporter
(experimentally veriﬁed with radio- and stable-
isotope labelled choline, T. K. Smith, unpublished
observations), suggests that all T. brucei choline
comes from endocytosed choline containing phos-
pholipids such as PC, lyso-PC and SM, some of
which (probably a large proportion) will be endo-
cytosed as low density lipoprotein particles (Overath
and Engstler, 2004).
A search in the genomic database for trypano-
somatid pathogens, the Tri-TrypDB (http://tritrypdb.
org/), revealed that the PE N-methyltransferase genes
are also absent in T. cruzi, but are present in
Leishmaina species; their presence has been exper-
imentally conﬁrmed in Leishmania major (T.K.
Smith, unpublished observation), while in Plas-
modium falciparum they have plant-like N-methyl-
transferase genes (Pessi et al. 2005).
PS composition
The molecular composition of PS species in T. brucei
has not been determined before, but it accounts for
3% of the total PL in T. brucei. Scanning for a
neutral loss of m/z 87 from collision-induced dis-
sociation of ions in negative mode speciﬁcally ident-
iﬁes PS molecules (Figs S4 A and B, Appendix). The
Fig. 5. Molecular composition of PE, PS, PA and PG species in T. brucei. Precursor ion scanning for m/z 196
speciﬁcally detected [M−H]− PE ions from PCF and trypanosome total lipid extracts see Fig. S3. Molecular species are
plotted against their relative percentage based upon TIC, PCF (BLACK) and BSF (GREY). Peak assignments are
based on MS-MS daughter ion spectra performed as stated in the Material and Methods section, and a letter annotates
each peak series, which are annotated in Tables S3–S6.
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PS pool in PCF and BSF T. brucei contains a variety
of diacyl and ether molecular species (Tables S5 and
S6 respectively, see Appendix), the latter of which is
60–77% in the alkylacyl subclass (Fig. 5). The most
intense signal stems fromm/z 772 (Figs. S4 A and B),
which represents the [M−H]− ion of PS (a-18:0/
18:2) . Nearly a quarter (24%) of all PS species are
of the diacyl series 36:y in BSF trypanosomes but this
level is decreased to12% in PCF cells (Fig. 5), along
with a signiﬁcant decrease in the amount of series
40:y, probably due to a lack of host PUFA as
discussed for the PE species. These two observed
diﬀerences probably account for most of the increase
in diacyl PS in BSF compared to PCF trypanosomes
(Patnaik et al. 1993).
PS can also be detected in positive ion mode by
scanning for the neutral loss of m/z 185. Performing
this scan from total lipids in BSF and PCF parasites
revealedmoremolecular species of PS than did them/
z 87 neutral loss scan (data not shown). However, as
Fig. 6. T. brucei have no N-methyltransferases capable of converting PE to PC. ESI-MS/MS spectra of the following
molecular species; PE (A); (d4)-PE (B); PC (C); (d4)-PC (D), in BSF T. brucei labelled with (d4)-ethanolamine. Data
were normalised to the largest peak and vertical axes linked in order to directly compare the intensities of non-deuterated
vs. deuterated phospholipid species. Also shown are the molecular structures of the relevant collision-induced
fragments.
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with the alternative PE scan, the intensities of the
diacyl and ether PE signals did not match the known
abundances of those subclasses. Ether PS makes up
81–88% and 61% of all PS in PCF and BSF cells,
respectively (Fig. 5), but the neutral lossm/z 185 scan
in the BSF, for example, only showed a cumulative
ether PS content of approximately 10% of total PS
(data not shown).
PE cannot be formed by decarboxylation of PS in
BSF T. brucei
A possible alternative route to the Kennedy pathway
for the biosynthesis of PE is the decarboxylation of
PS. The contributions of the two pathways to the
cellular pattern of PE are organism and cell-type
dependent. PS decarboxylation is actually the sole
route for PE biosynthesis in E. coli (Kanfer and
Kennedy, 1963) and the major one in S. cerevisiae,
although in yeast the Kennedy pathway is also active
(Dowhan, 1997). In mammalian cells, the relative
contributions of these pathways to PE formation is
cell-type dependent, with PS decarboxylation pre-
vailing in BHK21 and CHO cells and the Kennedy
pathway prevailing in most mammalian tissues, and
cultured glioma cells (Vance, 2008) (Fig. 7A).
The relative contribution of the PS decarboxy-
lation pathway to PE in BSF T. brucei has been
assessed by us using stable isotope labelling, with
d3-serine and subsequent analysis by ESI-MS/MS
(Gibellini et al. 2009). The d3-serine is readily in-
corporated into d3-PS, but it was unable to form any
d3-PE from d3-PS via decarboxylation – thus high-
lighting the importance of the Kennedy pathway in
the biosynthesis of PE in bloodstream-form T. brucei
(Gibellini et al. 2008). This was conﬁrmed by the
genetic validation, via a conditional knockout, of
the ECT gene in which PS decarboxylation was not
unregulated to compensate for the loss of the de novo
synthesized PE (Gibellini et al. 2009). These ﬁndings
are in contradiction with previous work (Menon et al.
1993; Rifkin et al. 1995), which indicated that
bloodstream form T. brucei was able to synthesise
PE from PS via decarboxylation. This diﬀerence may
be due to variations in the experimental conditions,
while the stable-isotope labelling experiments were
conducted under steady-state conditions with ample
levels of serine, the radiolabelling experiments were
conducted over a short period of time (1 hour), as well
as in serine-freemedia, whichmay trigger diﬀerential
usage of the sparingly available serine which is also
required for protein synthesis. One also has to
consider if the freshly synthesised PS will be de-
carboxylated preferentially over the pre-existing pool
of PS, and if it is in the correct cellular location, i.e.
available to the PS decarboxylase.
Despite our lack of observable PS decarboxylase
activity, preliminary results from the laboratory
suggest that the putative T. brucei PS decarboxylase
gene (Tb09.211.1610) appears to be essential in
the bloodstream form of the parasite (T. K. Smith,
unpublished observations).
In procyclic forms, decarboxylation of PS to
PE occurs to a limited extent but it is insuﬃcient
to compensate for the disruption of the CDP-
ethanolamine branch of the Kennedy pathway
(Signorrell et al. 2008). Together, these ﬁndings
raise the question, what is the role/function of the
PS decarboxylase? Possibly it is highly regulated
and/or has a very speciﬁc, but as yet unknown
function.
The absence of the PE methylation pathway and
the irrelevance of PS decarboxylation as a contributor
to the steady-state molecular composition of PE,
indicate that phospholipid metabolism and its regu-
lation are diﬀerent and less complex in BSF T. brucei
(Fig. 7), than in higher eukaryotes including man.
T. brucei selectively carries out PC and PE for-
mation via the CDP-choline and CDP-ethanolamine
branches of the Kennedy pathway (Gibellini et al.
2008), whereas in yeast, PC and PE are synthesised
primarily by PEmethylation and PS decarboxylation
(Carman and Han, 2009); that is, pathways involving
CDP-DAG. Also, in mammalian cells, PS decarbox-
ylation is a major route for PE biosynthesis (Vance,
2008) and PE methylation activity is abundant in
hepatocytes (Walkey et al. 1998). The less convoluted
interconnections between phospholipid biosynthetic
pathways make the African trypanosome a desirable
system for studying lipid metabolism and the ﬂuxes
required to maintain lipid homeostatis (Fig. 7B).
At the same time the absence of alternative ‘salvage’
routes for the biosynthesis of PC and PE renders
both branches of the Kennedy pathway attractive
potential drug targets. Recently we have genetically
validated the ethanolamine branch of the Kennedy
pathway as a drug target (Gibellini et al. 2009),
and preliminary data on genetic validation of the
choline kinase (Young, Gibellini and Smith, unpub-
lished observations), suggests the choline branch of
the Kennedy pathway could also be successfully
targeted.
Inositol PL composition
PI molecular species were detected from precursor
ion scanning for m/z 241 in negative ion mode
(Fig. S5A and B, Tables S7 and S8, see Appendix).
There are signiﬁcant diﬀerences in the inositol PL
composition of PCF and BSF trypanosomes (Fig. 8).
In PCFs, the largest peak area is composed of
molecular species in the 36:y series of PI whereas in
BSFs it is the 40:y series. Daughter ion scanning
showed that the 40:y series is mostly made up of
PI (18:0/22:4–22:6). The signiﬁcant decline of
these molecular species in PCF cells could reﬂect
the signiﬁcant decrease in demand to synthesise
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glycosylphosphatidylinositol in this form of the
parasite compared to BSF cells, as well as the
formation of inositol phosphoceramide (IPC) in
PCF, which varies in amounts from 5–15% of total
inositol PLs (Fig. 8). Furthermore, diacyl and ether
PI species containing shorter FAs were present in
PCF PI (Fig. S5A and B, Tables S7 and S8, see
Appendix), whereas these molecular species and IPC
were not detected in the BSF analysis.
It was previously thought that BSF trypanosomes
only contained diacyl PI (Patnaik et al. 1993), but the
data generated from this study showed that the diacyl
subclass constitutes 80% and 90% of total PI in PCF
and BSF trypanosomes, respectively, and that ether
Fig. 7. De novo synthesis of PE, PS and PC in mammals (A) and T. brucei (B). Intermediates: Cho, choline; Cho-P,
phosphocholine; CDP-Cho, cytidine-diphosphocholine; PC, phosphatydylcholine; Etn, ethanolamine; Etn-P,
phosphoethanolamine; CDP-Etn, cytidine-diphosphoethanolamine; PE, phosphatidylethanolamine; DAG,
diacylglycerol; AAG, alkylacylglycerol. Enzymes: CK, choline kinase (Tb927.5.1140); CCT, phosphocholine
cytidylyltransferase (Tb10.389.0730); CPT, choline phosphotransferase (Tb10.389.0730, Tb10.6k15.1570); EK,
ethanolamine kinase (Tb11.18.0017, Tb927.5.1140); ECT, phosphoethanolamine cytidylyltransferase (Tb11.01.5730);
EPT, ethanolamine phosphotransferase (Tb10.389.01-40, Tb 10.6k15.1570); PSD, phosphatidylserine decarboxylase
(Tb09.211.1610); PSS, phosphatidylserine synthase.
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lipids are certainly present in both PCF and BSF cells
(Fig. 8).
Despite IPC being a major sphingolipid in other
trypanosomatids (Kaneshiro et al. 1986; Bertello
et al. 1995; Uhrig et al. 1996; Zhang et al. 2007), and
it being observed previously in PCF T. brucei
(Güther et al. 2008), its role remians unclear. How-
ever, IPC has been observed at high concentrations
(50% of the total inositol PLs) in puriﬁed mito-
chondria (Güler et al. 2006), suggesting a signiﬁcant
role/synthesis in this organelle. Interestly, we have
also recently observed IPC formation in stumpy
BSF, and this has been associated with the up-
regulation of one of the four sphingomyelin synthases
responsible for IPC formation (Kabani et al. 2009;
Milna et al. 2009).
Other acidic PLs
PA, which is an important molecule in protein and
membrane transport, has the simplest polar head-
group (a phosphate) among the PL classes and readily
forms [M−H]− ions. As in other eukaryotic cells
PA is present in only modest quantities in T. brucei,
and it can only be detected by precursor ion scanning
for m/z 153 in negative ion mode, which detects
negative ions from all glycerophospholipids (Fig. S6,
see Appendix). Detection of lyso-PA [M−H]− and
Fig. 8. Molecular composition of inositol-containing PLs in T. brucei. Precursor ion scanning for m/z 241 speciﬁcally
detected [M−H]− PI and IPC ions from PCF and BSF trypanosome total lipid extracts, see Fig. S5. Molecular species
are plotted against their relative percentage based upon TIC, PCF (BLACK) and BSF (GREY). Peak assignments are
based on MS-MS daughter ion spectra performed as stated in the Material and Methods section, and each peak series is
annotated by a letter, which are annotated in Tables S7 and S8.
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its associated FA ions formed from collision-induced
dissociation of PA [M−H]− ions conﬁrmed its
presence among the more abundant PLs. The mol-
ecular species variation among PA appears to be very
similar to the species distribution of the other PLs,
and they exist as both diacyl and ether lipid subclasses
(Fig. 5). As with the other PLs in T. brucei, some PA
contains long-chain highly unsaturated molecular
species, which by MS-MS showed to be mostly PA
(16:0/22:6) (719m/z), PA (16:0/22:5) (721 m/z), PA
(18:0/22:6) (747m/z) and PA (18:0/22:5) (749m/z).
PG is also a minor component in both BSF and
PCFT. bruceimembranes and the neutral headgroup
of PG precludes its speciﬁc detection but it can be
most easily detected with other PLs by scanning
for m/z 153 in negative ion mode (Fig. S6, see
Appendix). Collision-induced decomposition of 757,
759 and 809m/z showed that ether PG is also present
in these cells. PG is also a minor component in both
BSF and PCF T. brucei membranes and serves as a
precursor for the synthesis of cardiolipin, which is an
essential lipid component of mitochondria T. brucei
membranes (Dixon and Williamson, 1970) where it
maintains the membrane potential. Previously we
have also observed cardolipin species in puriﬁed PCF
mitochondria (Güler et al. 2008), along with several
other phospholipids including very minor amounts
of ethanolamine phosphoceramide (Sutterwala et al.
2008), and signiﬁcant amounts of PIP2 and PIP3.
(T. K. Smith, unpublished observation). These will
be discussed and fully characterized in subsequent
work on the lipidomes of individual organelles from
T. brucei and other protozoa.
CONCLUSION
MS technology adapted to nanoﬂow mode has made
it possible to eﬃciently detect all the major T. brucei
PLs in one liquid sample of total lipid extract.Overall,
the results presented here for the composition of
diacyl PC, PE and PI agree with those obtained using
older methods that were not suitable for routine
analysis. In addition, we have elucidated for the ﬁrst
time the molecular species composition for PS, PA
and PG. These analyses also show that the T. brucei
PL pools exhibit greater heterogeneity in their alkyl-
acyl and alkenylacyl species than previously thought.
The most signiﬁcant contrast between PCF and BSF
PL composition is the inositol-containing PLs, i.e.
the formation of the non-mammalian like sphingo-
lipid IPC, in the PCF.
Though relatively little information is still known
about lipid biosynthesis inT. brucei and other kineto-
plastids, the remarkable variation in PL molecular
species and the large quantities of HUFAs present
in T. brucei PLs testify to the competency of this
obligate parasite to control its own fatty acid and thus
lipid composition despite being reliant upon lipid
precursors from its hosts.
The simpliﬁed aminophospholipid metabolism,
i.e. the lack of interconversion of PS to PE to PC,
is in direct contrast to that in humans and other
mammals (compare Fig. 7A and B). This puts the
parasite at a distinct disadvantage, as it also appears
that these de novo pathways are essential and thus
contain promising drug targets. The lack of cross-talk
between these de novo phospholipid pathways also
makes T. brucei an ideal organism in which to study
metabolic ﬂuxes in these pathways.
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APPENDIX 1 . SUPPLEMENTARY DATA
Table S1. Mass spectrometry analysis of PC and SM molecular species in the procyclic form of T. brucei
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
A′ (0·2%)
1 520·28 18:2 0:0/18:2 520·3398
2 522·30 18:1 0:0/18:1 522·3554
3 524·34 18:0 0:0/18:0 524·3711
B′
4 544·33 20:4 0:0/20:4 544·3398
5 546·34 20:3 0:0/20:3 546·3554
6 548·34 20:2 0:0/20:2 548·3711
C′ (0·2%)
7 568·35 22:6 0:0/22:6 568·3398
8 570·38 22:5 0:0/22:5 570·3554
9 572·38 22:4 0:0/22:4 572·3711
D′
10 646·44 26:2 0:0/26:2 646·4443
11 648·46 26:1 0:0/26:1 648·4599
12 650·48 26:0 0:0/26:0 650·4756
E′
13 660·60 a-28:2 a-14:0/14:2 660·5363
14 663·57 a-28:1 a-14:0/14:1 662·5119
15 664·54 a-28:0 a-14:0/14:0 664·5276
A (0·3%)
16 674·47 28:2 14:0/14:2 674·4756
17 676·51 28:1 14:0/14:2 676·4912
18 675·53 SM(14:0) Cer d18:0/14:1 676·5541
19 878·51 28:0 14:0/14:0 678·5069
B (0·1%)
20 686·33 e-30:2 e-14:1/16:2 686·5220
21 686·48 e-30:1, a-30:2 a-14:0/16:2 688·5376
22 690·53 e-30:0, a-30:1 a-14:0/16:1 690·5432
23 692·52 a-30:0 a-14:0/16:0 692·5589
C (0·4%)
24 698·50 30:4 16:2/14:2 698·4756
25 700·53 30:3 16:2/14:1 700·4912
26 703·56 30:2 16:0/14:2 703·5169
27 704·61 SM (16:0) Cer d18:0/16:1 704·5851
28 704·57 30:1 16:0/14:1 704·5225
29 706·55 30:0 16:0/14:0 706·5382
D (0·2%)
30 716·59 e-32:1, a-32:2 e-16:1/16:1 716·5589
31 718·58 e-32:0, a-32:1 e-16:1/16:0 718·5745
32 720·60 a-32:0 a-16:0/16:0 720·5902
E (1·8%)
33 728·52 32:3 16:1/16:2 728·5225
34 730·53 32:2 16:0/16:2 730·5382
35 732·55 32:1 16:0/16:1 732·5538
36 732·61 SM(18:0) Cer d18:0/18:1 732·6167
37 734·59 32:0 16:0/16:0 734·5695
F (1·5%)
38 738·54 e-34:4, a-34:5 a-14:0/20:5 738·5433
39 740·58 e-34:3, a-34:4 a-14:0/20:4 740·5589
40 742·57 e-34:2, a-34:3 a-14:0/20:3 742·5745
41 744·60 e-34:1, a-34:2 a-16:0/18:2 744·5902
42 746·61 e-34:0, a-34:1 a-16:0/18:1 746·6058
43 748·61 a-34:0 a-16:0/16:0 748·6215
G (3·9%)
44 754·54 34:4 16:2/18:2 754·5382
45 756·55 34:3 16:1/18:2 756·5538
46 758·57 34:2 16:0/18:2 758·5695
47 759·62 SM(20:0) Cer18:1/20:0 759·6401
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Table S1. (Cont.)
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
48 760·59 34:1 16:0/18:1 760·5851
49 762·62 34:0 16:0/18:0 762·6008
H (12·5%)
50 766·58 e-36:4, a-36:5 e-16:1/20:4 766·5745
51 768·57 e-36:3, a-36:4 a-16:0/20:4 768·5902
52 770·61 e-36:2, a-36:3 e-18:1/18:2 770·6058
53 772·64 e-36:1, a-36:2 a-18:0/18:2 772·6215
54 774·63 e-36:0, a-36:1 a-18:0/18:1 774·6371
55 776·62 a-36:0 a-18:0/18:0 776·6528
I (20·8%)
56 778·55 36:6 16:2/20:4 778·5382
57 780·54 36:5 16:1/20:4 780·5538
58 782·55 36:4 16:0/20:4 782·5695
59 784·56 36:3 18:1/18:2 784·5851
60 786·60 36:2 18:0/18:2 & 18:1/18:1 786·6008
61 788·57 36:1 18:0/18:1 788·6164
62 789·64 SM(22:0) Cer18:0/22:0 789·68
64 790·60 36:0 18:0/18:0 790·6321
J (1·7%)
63 790·54 e-38:6 e-16:1/22:6 790·5745
65 792·57 e-38:5, a-36:6 a-16:0/22:6 792·5902
66 794·54 e-38:4, a-38:5 e-18:1/20:4 794·5695
67 796·84 e-38:3, a-38:4 a-18:0/20:4 796·6215
68 798·64 e-38:2, a-38:3 e-18:1/20:2 798·6371
69 800·68 e-38:1, a-38:2 a-18:0/20:2 800·6528
70 802·68 e-38:0, a-38:1 a-18:0/20:1 802·6684
71 804·54 38:7 16:1/22:6 804·5538
72 804·69 a-38:0 a-18:0/20:0 804·6841
K (9·7%)
73 806·53 38:6 16:0/22:6 806·5695
74 808·53 38:5 16:0/22:5 808·5851
75 810·59 38:4 18:0/20:4 & 16:0/22:4 810·6008
76 812·61 38:3 18:0/20:3 812·6164
77 814·64 38:2 18:0/20:2 814·6321
78 816·64 38:1 18:0/20:1 816·6477
79 818·68 38:0 18:0/20:0 818·6634
L (1·5%)
80 818·58 e-40:6 e-18:1/22:6 818·6058
81 820·63 e-40:5, a-40:6 a-18:0/22:6 820·6215
82 822·64 e-40:4, a-40:5 e-18:1/22:4 822·6371
83 824·65 e-40:3, a-40:4 a-18:0/22:4 824·6528
84 826·64 e-40:2, a-40:3 e-18:1/22:2 826·6321
85 828·67 e-40:1, a-40:2 a-18:0/22:2 828·6841
86 830·69 e-40:0, a-40:1 e-18:1/22:0 830·6997
87 832·72 a-40:0 a-18:0/22:0 832·7154
M (36·1%)
88 830·56 40:8 18:2/22:6 830·5695
89 832·58 40:7 18:1/22:6 832·5851
90 834·61 40:6 18:0/22:6 834·6008
91 836·61 40:5 18:0/22:5 836·6164
92 838·63 40:4 18:2/22:4 838·6321
93 840·65 40:3 18:1/22:2 840·6477
94 842·67 40:2 18:0/22:2 842·6634
95 844·71 40:1 18:1/22:0 844·6790
96 846·72 40:0 18:0/22:0 846·6947
97 848·68 e-42:6 e-18:1/24:6 848·6528
98 850·69 e-42:5 e-18:1/24:4 850·6684
99 852·70 a-42:4 a-18:0/24:4 852·6841
N (4·6%)
101 852·59 42:11 20:4/22:5 852·5538
102 854·72 a-42:3 e-18:1/24:2 854·6997
103 854·57 42:10 20:4/22:6 854·5695
104 856·73 a-42:2 a-18:0/24:2 856·7154
105 856·61 42:9 20:4/22:5 856·5851
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Table S1. (Cont.)
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
106 858·75 a-42:1 a-18:1/24:0 858·7310
107 858·60 42:8 18:2/24:6 858·6008
108 860·61 42:7 18:1/24:6 860·6164
109 860·73 a-42:0 a-18:0/24:0 860·7467
110 862·64 42:6 18:0/24:6 862·6321
111 864·65 42:5 18:0/24:5 864·6477
112 866·66 42:4 18:2/24:4 866·6634
113 868·67 42:3 18:1/24:2 868·6790
114 870·72 42:2 18:0/24:2 870·6947
115 872·73 42:1 18:1/24:0 872·7103
116 874·74 42:0 18:0/24:0 874·7260
O (4·4%)
117 878·58 44:12 20:6/24:6 878·5695
118 852·59 44:11 20:6/24:5 852·5565
119 882·59 44:10 20:4/24:6 882·6008
120 886·62 44:8 20:4/24:4 886·6321
121 888·63 44:7 20:2/24:5 888·6477
122 890·64 44:6 20:1/24:6 890·6634
123 892·65 44:5 20:0/24:5 892·6790
124 894·66 44:4 18:0/26:4 894·6947
125 896·67 44:3 20:1/24:2 896·7103
126 898·70 44:2 20:0/24:2 898·7260
127 900·71 44:1 18:0/26:1 900·7416
128 902·72 44:0 18:0/26:0 902·7573
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 4A. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PC/SM species are in bold.
b HR [M+H]+ ions, mass over charge values (high resolution survey scan) ±0·05m/z were obtained as described in
Materials and Methods.
c Peak identities refer to total number of carbon atoms and double bonds. e=plasmenyl (alkenylacyl); a=plasmanyl
(alkylacyl).
d Precise fatty acyl constituents and their positions are not discernable in positive ion mode; however, where possible, the
most likely fatty acid candidates for the sn-1 and sn-2 constituents of the molecular species presented were deduced from the
available literature. Only the principal component is given, in some instances as many as 5 individual species, with diﬀerent
combinations of acyl chains result in the same total number of carbon atoms and double bonds.
e Theoretical monoisotopic masses were obtained were possible for LIPIDMAPS, otherwise they were calculated using
http://www.sisweb.com/referenc/tools/exactmass.htm.
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Table S2. Mass spectrometry analysis of PC and SM molecular species in the bloodstream form of T. brucei
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
A′
1 520·30 18:2 0:0/18:2 520·3398
2 522·31 18:1 0:0/18:1 522·3554
3 524·33 18:0 0:0/18:0 524·3711
B′
4 544·34 20:4 0:0/20:4 544·3398
5 546·32 20:3 0:0/20:3 546·3554
6 548·37 20:2 0:0/20:2 548·3711
C′
7 568·35 22:6 0:0/22:6 568·3398
8 570·37 22:5 0:0/22:5 570·3554
9 572·37 22:4 0:0/22:4 572·3711
D′
10 646·45 26:2 0:0/26:2 646·4443
11 648·47 26:1 0:0/26:1 648·4599
12 650·49 26:0 0:0/26:0 650·4756
E′
13 660·59 a-28:2 a-14:0/14:2 660·5363
14 663·55 a-28:1 a-14:0/14:1 662·5119
15 664·51 a-28:0 a-14:0/14:0 664·5276
A (0·2%)
16 674·49 28:2 14:0/14:2 674·4756
17 676·52 28:1 14:0/14:2 676·4912
18 675·52 SM(14:0) Cer d18:0/14:1 676·5541
19 878·53 28:0 14:0/14:0 678·5069
B (0·2%)
20 686·32 e-30:2 e-14:1/16:2 686·5220
21 686·29 e-30:1, a-30:2 a-14:0/16:2 688·5376
22 690·56 e-30:0, a-30:1 a-14:0/16:1 690·5432
23 692·53 a-30:0 a-14:0/16:0 692·5589
C (0·2%)
24 698·49 30:4 16:2/14:2 698·4756
25 700·52 30:3 16:2/14:1 700·4912
26 703·54 30:2 16:0/14:2 703·5169
27 704·62 SM (16:0) Cer d18:0/16:1 704·5851
28 704·55 30:1 16:0/14:1 704·5225
29 706·54 30:0 16:0/14:0 706·5382
D (0·4%)
30 716·57 e-32:1, a-32:2 e-16:1/16:1 716·5589
31 718·59 e-32:0, a-32:1 e-16:1/16:0 718·5745
32 720·62 a-32:0 a-16:0/16:0 720·5902
E (1·2%)
33 728·54 32:3 16:1/16:2 728·5225
34 730·55 32:2 16:0/16:2 730·5382
35 732·57 32:1 16:0/16:1 732·5538
36 732·64 SM(18:0) Cer d18:0/18:1 732·6167
37 734·58 32:0 16:0/16:0 734·5695
F (1·8%)
38 738·58 e-34:4, a-34:5 a-14:0/20:5 738·5433
39 740·57 e-34:3, a-34:4 a-14:0/20:4 740·5589
40 742·59 e-34:2, a-34:3 a-14:0/20:3 742·5745
41 744·63 e-34:1, a-34:2 a-16:0/18:2 744·5902
42 746·63 e-34:0, a-34:1 a-16:0/18:1 746·6058
43 748·61 a-34:0 a-16:0/16:0 748·6215
G (4·8%)
44 754·55 34:4 16:2/18:2 754·5382
45 756·57 34:3 16:1/18:2 756·5538
46 758·59 34:2 16:0/18:2 758·5695
47 759·62 SM(20:0) Cer18:1/20:0 759·64
48 760·59 34:1 16:0/18:1 760·5851
49 762·62 34:0 16:0/18:0 762·6008
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Table S2. (Cont.)
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
H (13·0%)
50 766·55 e-36:4, a-36:5 e-16:1/20:4 766·5745
51 768·55 e-36:3, a-36:4 a-16:0/20:4 768·5902
52 770·62 e-36:2, a-36:3 e-18:1/18:2 770·6058
53 772·65 e-36:1, a-36:2 a-18:0/18:2 772·6215
54 774·63 e-36:0, a-36:1 a-18:0/18:1 774·6371
55 776·63 a-36:0 a-18:0/18:0 776·6528
I (19·1%)
56 778·55 36:6 16:2/20:4 778·5382
57 780·53 36:5 16:1/20:4 780·5538
58 782·53 36:4 16:0/20:4 782·5695
59 784·56 36:3 18:1/18:2 784·5851
60 786·59 36:2 18:0/18:2 & 18:1/18:1 786·6008
61 788·57 36:1 18:0/18:1 788·6164
62 789·65 SM(22:0) Cer18:0/22:0 789·68
64 790·61 36:0 18:0/18:0 790·6321
J (1·4%)
63 790·54 e-38:6 e-16:1/22:6 790·5745
65 792·57 e-38:5, a-36:6 a-16:0/22:6 792·5902
66 794·54 e-38:4, a-38:5 e-18:1/20:4 794·5695
67 796·84 e-38:3, a-38:4 a-18:0/20:4 796·6215
68 798·64 e-38:2, a-38:3 e-18:1/20:2 798·6371
69 800·68 e-38:1, a-38:2 a-18:0/20:2 800·6528
70 802·68 e-38:0, a-38:1 a-18:0/20:1 802·6684
71 804·54 38:7 16:1/22:6 804·5538
K (13·6%)
72 804·69 a-38:0 a-18:0/20:0 804·6841
73 806·53 38:6 16:0/22:6 806·5695
74 808·53 38:5 16:0/22:5 808·5851
75 810·58 38:4 18:0/20:4 & 16:0/22:4 810·6008
76 812·60 38:3 18:0/20:3 812·6164
77 814·62 38:2 18:0/20:2 814·6321
78 816·63 38:1 18:0/20:1 816·6477
79 818·57 e-40:6 e-18:1/22:6 818·6058
80 818·67 38:0 18:0/20:0 818·6634
L (1·6%)
81 820·61 e-40:5, a-40:6 a-18:0/22:6 820·6215
82 822·61 e-40:4, a-40:5 e-18:1/22:4 822·6371
83 824·63 e-40:3, a-40:4 a-18:0/22:4 824·6528
84 826·61 e-40:2, a-40:3 e-18:1/22:2 826·6321
85 828·68 e-40:1, a-40:2 a-18:0/22:2 828·6841
86 830·68 e-40:0, a-40:1 e-18:1/22:0 830·6997
87 832·70 a-40:0 a-18:0/22:0 832·7154
M (34·4%)
88 830·55 40:8 18:2/22:6 830·5695
89 832·57 40:7 18:1/22:6 832·5851
90 834·59 40:6 18:0/22:6 834·6008
91 836·59 40:5 18:0/22:5 836·6164
92 838·62 40:4 18:2/22:4 838·6321
93 840·65 40:3 18:1/22:2 840·6477
94 842·68 40:2 18:0/22:2 842·6634
95 844·72 40:1 18:1/22:0 844·6790
96 846·73 40:0 18:0/22:0 846·6947
97 848·66 e-42:6 e-18:1/24:6 848·6528
98 850·66 e-42:5 e-18:1/24:4 850·6684
99 852·68 a-42:4 a-18:0/24:4 852·6841
N (3·8%)
101 852·59 42:11 20:4/22:5 852·5538
102 854·72 a-42:3 e-18:1/24:2 854·6997
103 854·57 42:10 20:4/22:6 854·5695
104 856·73 a-42:2 a-18:0/24:2 856·7154
105 856·59 42:9 20:4/22:5 856·5851
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Table S2. (Cont.)
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
106 858·75 a-42:1 a-18:1/24:0 858·7310
107 858·59 42:8 18:2/24:6 858·6008
108 860·57 42:7 18:1/24:6 860·6164
109 860·72 a-42:0 a-18:0/24:0 860·7467
110 862·61 42:6 18:0/24:6 862·6321
111 864·63 42:5 18:0/24:5 864·6477
112 866·66 42:4 18:2/24:4 866·6634
113 868·69 42:3 18:1/24:2 868·6790
114 870·73 42:2 18:0/24:2 870·6947
115 872·73 42:1 18:1/24:0 872·7103
116 874·75 42:0 18:0/24:0 874·7260
O (3·0%)
117 878·59 44:12 20:6/24:6 878·5695
118 852·58 44:11 20:6/24:5 852·5565
119 882·59 44:10 20:4/24:6 882·6008
120 886·61 44:8 20:4/24:4 886·6321
121 888·61 44:7 20:2/24:5 888·6477
122 890·62 44:6 20:1/24:6 890·6634
123 892·63 44:5 20:0/24:5 892·6790
124 894·65 44:4 18:0/26:4 894·6947
125 896·68 44:3 20:1/24:2 896·7103
126 898·70 44:2 20:0/24:2 898·7260
127 900·72 44:1 18:0/26:1 900·7416
128 902·73 44:0 18:0/26:0 902·7573
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 4B. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PC/SM species are in bold.
b As in Table S1.
c As in Table S1.
d As in Table S1.
e As in Table S1.
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Table S3. Mass spectrometry analysis of PE molecular species in procyclic T. brucei
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
A (0·7%)
1 684·36 32:3 16:1/16:2 684·4610
2 686·42 32:2 16:0/16:2 686·4766
3 688·44 32:1 16:0/16:1 688·4923
4 690·47 32:0 16:0/16:0 690·5079
B (1·5%)
5 696·52 a-34:4 e-16:1/18:3 696·4973
6 698·52 a-34:3 e-16:1/18:2 698·5130
7 700·54 a-34:2 a-16:0/18:2 700·5286
8 702·55 a-34:1 a-16:0/18:1 702·5443
C (3·2%)
9 710·49 34:4 16:1/18:3 710·4766
10 712·52 34:3 16:1/18:2 712·4923
11 714·54 34:2 16:0/18:2 714·5079
12 716·55 34:1 16:0/18:1 716·5236
13 718·56 34:0 16:0/18:0 718·5392
D (72·5%)
14 724·54 a-36:5 a-18:1/18:4 724·5286
15 726·58 a-36:4 a-18:1/18:3 726·5443
16 728·58 a-36:3 a-18:1/18:2 728·5599
17 730·59 a-36:2 a-18:1/18:1 730·5756
18 732·61 a-36:1 a-18:0/18:1 732·5912
19 734·62 a-36:0 a-18:0/18:0 734·6068
E (10·9%)
20 738·53 36:4 18:2/18:2 738·5079
21 740·55 36:3 18:1/18:2 740·5236
22 742·56 36:2 18:0/18:2 742·5392
23 744·58 36:1 18:0/18:1 744·5549
24 746·59 36:0 18:0/18:0 746·5705
F (6·3%)
25 748·56 a-38:6 e-18:1/20:5 748·5286
26 750·56 a-38:5 e-18:1/20:4 750·5443
27 752·57 a-38:4 a-18:0/20:4 752·5599
28 754·59 a-38:3 a-18:0/20:3 754·5756
29 756·62 a-38:2 a-18:0/20:3 756·5912
30 758·63 a-38:1 a-18:0/20:2 758·6069
31 760·64 a-38:0 a-18:0/20:1 760·6225
G (1·9%)
32 762·53 38:6 18:2/20:4 762·5079
33 764·55 38:5 18:1/20:4 764·5236
34 766·56 38:4 18:0/20:4 766·5392
35 768·57 38:3 18:0/20:3 768·5549
36 770·58 38:2 18:0/20:2 770·5705
37 772·60 38:1 18:0/20:1 772·5862
38 774·64 38:0 18:0/20:0 774·6018
H (0·3%)
39 774·57 e-40:6, a-40:7 e-18:1/22:6 774·5443
40 776·59 a-40:6 a-18:1/22:5 776·5599
I (2·6%)
41 788·54 40:7 18:2/22:5 788·5236
42 790·57 40:6 18:1/22:5 790·5392
43 792·58 40:5 18:1/22:4 792·5549
44 794·59 40:4 18:0/22:4 794·5705
45 796·61 40:3 18:1/22:2 796·5862
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 5A. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PE species are in bold.
b HR[M−H]− ions mass over charge values (high resolution survey scan) ±0·05m/z were obtained as described in
Materials and Methods. (high resolution survey scan) ±0·05m/z were obtained as described in material methods.
c As in Table S1.
d Precise fatty acyl sn-1 and sn-2 constituents were deduced from daughter ion scanning, only the principal component is
given, in some instances there are asmany as 5 individual species, with diﬀerent combinations of acyl groups, resulting in the
same total number of carbon atoms and double bonds.
e As in Table S1.
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Table S4. Mass spectrometry analysis of PE molecular species in bloodstream T. brucei
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
B (2·4%)
1 696·50 a-34:4 e-16:1/18:3 696·4973
2 698·51 a-34:3 e-16:1/18:2 698·5130
3 700·53 a-34:2 a-16:0/18:2 700·5286
4 702·55 a-34:1 a-16:0/18:1 702·5443
C (3·5%)
5 710·48 34:4 16:1/18:3 710·4766
6 712·50 34:3 16:1/18:2 712·4923
7 714·51 34:2 16:0/18:2 714·5079
8 716·53 34:1 16:0/18:1 716·5236
9 718·56 34:0 16:0/18:0 718·5392
D (57·8%)
10 724·53 a-36:5 a-18:1/18:4 724·5286
11 726·54 a-36:4 a-18:1/18:3 726·5443
12 728·56 a-36:3 a-18:1/18:2 728·5599
13 730·58 a-36:2 a-18:1/18:1 730·5756
14 732·59 a-36:1 a-18:0/18:1 732·5912
15 734·60 a-36:0 a-18:0/18:0 734·6068
E (10·6%)
16 738·51 36:4 18:2/18:2 738·5079
17 740·53 36:3 18:1/18:2 740·5236
18 742·54 36:2 18:0/18:2 742·5392
19 744·56 36:1 18:0/18:1 744·5549
20 746·57 36:0 18:0/18:0 746·5705
F (3·1%)
21 748·54 a-38:6 e-18:1/20:5 748·5286
22 750·55 a-38:5 e-18:1/20:4 750·5443
23 752·57 a-38:4 a-18:0/20:4 752·5599
24 754·58 a-38:3 a-18:0/20:3 754·5756
25 756·60 a-38:2 a-18:0/20:3 756·5912
26 758·62 a-38:1 a-18:0/20:2 758·6069
27 760·62 a-38:0 a-18:0/20:1 760·6225
G (5·0%)
28 762·51 38:6 18:2/20:4 762·5079
29 764·52 38:5 18:1/20:4 764·5236
30 766·54 38:4 18:0/20:4 766·5392
31 768·56 38:3 18:1/20:2 768·5549
32 770·57 38:2 18:0/20:2 770·5705
33 772·59 38:1 18:0/20:1 772·5862
H (1·1%)
34 774·55 38:0 or a-40:7 e-18:1/22:6 774·5443
35 776·57 a-40:6 a-18:1/22:5 776·5599
I (10·1%)
36 788·54 40:7 18:2/22:5 788·5236
37 790·55 40:6 18:1/22:5 790·5392
38 792·55 40:5 18:1/22:4 792·5549
39 794·57 40:4 18:0/22:4 794·5705
40 796·59 40:3 18:1/22:2 796·5862
J (6·4%)
41 820·59 42:5 18:0/24:5 820·5862
42 822·60 42:4 18:0/24:4 822·6018
43 824·63 42:3 18:0/24:3 824·6175
44 826·64 42:2 18:0/24:2 826·6331
45 828·67 42:1 18:0/24:1 828·6488
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 5B. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PE species are in bold.
b As in Table S3.
c As in Table S1.
d As in Table S3.
e As in Table S1.
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Table S5. Mass spectrometry analysis of PS molecular species in procyclic T. brucei
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
A (1·0%)
1 756·50 34:3 16:1/18:2 756·4821
2 758·50 34:2 16:0/18:2 758·4977
3 760·50 34:1 16:0/18:1 760·5134
4 762·54 34:0 16:0/18:0 762·5290
B (69·9%)
5 768·50 a-36:4 a-16:0/20:4 768·5185
6 770·54 e-36:2 e-18:1/18:2 770·5341
7 772·55 a-36:2 a-18:0/18:2 772·5498
8 774·58 a-36:1 a-18:0/18:1 774·5654
9 776·59 a-36:0 a-18:0/18:0 776·5811
C (12·3%)
10 784·52 36:3 18:1/18:2 784·5134
11 786·54 36:2 18:0/18:2 786·5290
12 788·55 36:1 18:0/18:1 788·5447
13 790·57 36:0 18:0/18:0 790·5603
D (12·4%)
14 795·56 a-38:4 a-18:0/20:4 796·5498
15 798·57 a-38:3 a-18:1/20:2 798·5654
16 800·60 a-38:2 a-18:0/20:2 800·5811
17 802·61 a-38:1 a-18:1/20:0 802·5967
18 804·64 a-38:0 a-18:0/20:0 804·6123
E (1·2%)
19 806·48 38:6 18:2/20:4 806·4977
20 808·52 38:5 18:1/20:4 808·5134
21 810·54 38:4 18:0/20:4 810·5290
22 812·57 38:3 18:1/20:2 812·5447
23 814·58 38:2 18:0/20:2 814·5603
24 816·58 38:1 18:1/20:0 816·5760
25 818·60 38:0 18:0/20:0 818·5916
F (3·1%)
26 834·54 40:6 18:0/22:6 834·5290
27 836·57 40:5 18:1/22:4 836·5447
28 838·58 40:4 18:0/22:4 838·5603
29 840·60 40:3 18:1/22:2 840·5760
30 842·62 40:2 18:0/22:2 842·5916
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 7A. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PS species are in bold.
b As in Table S3.
c As in Table S1.
d As in Table S3.
e As in Table S1.
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Table S6. Mass spectrometry analysis of PE molecular species in bloodstream T. brucei
Peaka HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
A (1·1%)
1 756·46 34:3 16:1/18:2 756·4821
2 758·47 34:2 16:0/18:2 758·4977
3 760·52 34:1 16:0/18:1 760·5134
4 762·53 34:0 16:0/18:0 762·5290
B (54·5%)
5 768·53 a-36:4 a-16:0/20:4 768·5185
6 770·54 e-36:2 e-18:1/18:2 770·5341
7 772·55 a-36:2 a-18:0/18:2 772·5498
8 774·57 a-36:1 a-18:0/18:1 774·5654
9 776·60 a-36:0 a-18:0/18:0 776·5811
C (23·3%)
10 784·53 36:3 18:1/18:2 784·5134
11 786·55 36:2 18:0/18:2 786·5290
12 788·56 36:1 18:0/18:1 788·5447
13 790·57 36:0 18:0/18:0 790·5603
D (6·0%)
14 796·55 a-38:4 a-18:0/20:4 796·5498
15 798·57 a-38:3 a-18:1/20:2 798·5654
16 800·59 a-38:2 a-18:0/20:2 800·5811
17 802·62 a-38:1 a-18:1/20:0 802·5967
18 804·63 a-38:0 a-18:0/20:0 802·5967
E (2·4%)
19 806·51 38:6 18:2/20:4 806·4977
20 808·52 38:5 18:1/20:4 808·5134
21 810·54 38:4 18:0/20:4 810·5290
22 812·54 38:3 18:1/20:2 812·5447
23 814·55 38:2 18:0/20:2 814·5603
24 816·57 38:1 18:1/20:0 816·5760
25 818·58 38:0 18:0/20:0 818·5916
F (12·0%)
26 834·50 40:6 18:0/22:6 834·5290
27 836·52 40:5 18:0/22:5 836·5447
28 838·53 40:4 18:0/22:4 838·5603
29 840·55 40:3 18:1/22:2 840·5760
30 842·58 40:2 18:0/22:2 842·5916
G (0·4%)
31 854·48 42:10 20:4/22:6 854·4977
32 856·50 42:9 20:5/22:4 856·5134
33 858·51 42:8 20:2/22:6 858·5290
H (0·2%)
34 878·50 44:12 22:6/22:6 878·4977
35 880·52 44:11 20:6/24:5 880·5134
36 882·54 44:10 22:4/22:6 882·5290
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 7B. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PS species are in bold.
b As in Table S3.
c As in Table S1.
d As in Table S3.
e As in Table S1.
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Table S7. Mass spectrometry analysis of PI molecular species in procyclic T. brucei
Peaka m/z HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
A (1·3%) 749 749·43 28:2 14:1/14:1 749·4246
1 750 750·48 IPC 32:1 Cer 32:1 750·4921
2 751 751·44 28:1 14:0/14:1 751·4403
3 752 752·50 IPC 32:0 Cer 32:0 752·5099
4 753 753·45 28:0 14:0/14:0 753·4559
5
B (0·2%)
6 761 761·46 e-30:3 e-16:2/14:1 761·4613
7 763 763·49 a-30:2 e-16:1/14:1 763·4767
8 765 765·50 a-30:1 a-16:0/14:1 765·4923
9 767 767·53 a-30:0 a-16:0/14:0 767·5080
C (2·9%)
10 775 773·47 30:3 14:1/16:2 775·4403
11 777 777·49 30:2 16:1/14:1 777·4559
12 778 778·53 IPC 34:1 Cer 34:1 778·5234
13 779 779·51 30:1 16:1/14:0 779·4716
14 780 780·54 IPC 34:0 Cer 34:0 780·5412
15 781 781·52 30:0 16:0/14:0 781·4872
D (0·5%)
16 789 789·48 e-32:3 e-16:2/16:1 789·4924
17 791 791·53 a-32:2 e-16:1/16:1 791·5080
18 793 793·55 a-32:1 a-16:0/16:1 793·5236
19 795 795·55 a-32:0 a-16:0/16:0 795·5393
E (1·0%)
20 803 803·48 32:3 16:1/16:2 803·4716
21 805 8805·50 32:2 16:1/16:1 805·4872
22 806 806·55 IPC 36:1 Cer 36:1 806·5547
23 807 807·51 32:1 16:0/16:1 807·5029
24 808 808·57 IPC 36:0 Cer 36:0 808·5725
25 809 809·52 32:0 16:0/16:0 809·5185
F (0·4%)
26 815 815·59 e-34:3 e-16:1/18:3 815·5080
27 817 817·54 e-34:2 e-16:1/18:2 817·5236
28 819 819·56 a-34:2 a-16:0/18:2 819·5393
29 821 821·57 a-34:1 a-16:0/18:1 821·5549
30 823 .823·59 a-34:0 a-16:0/18:0 823·5706
G (5·1%)
31 829 829·52 34:4 14:0/20:4 829·4872
32 831 831·55 34:3 16:1/18:2 831·5029
33 832 832·58 IPC 38:1 Cer 38:1 832·5860
34 833 833·54 34:2 16:0/18:2 833·5185
35 834 834·64 IPC 38:0 Cer 38:0 .834·6038
36 835 835·56 34:1 16:0/18:1 835·5342
37 837 837·57 34:0 16:0/18:0 837·5498
H (5·8%)
38 843 843·56 e-36:3, a-36:4 a-16:0/20:4 843·5393
39 845 845·55 e-36:2, a-36:3 e-18:1/18:2 845·5549
40 847 847·58 e-36:1, a-36:2 a-18:0/18:2 847·5706
41 849 849·57 e-36:0, a-36:1 a-18:0/18:1 849·5862
42 851 851·59 a-36:0 a-18:0/18:0 851·6019
I (56·6%)
43 857 857·53 36:4 16:0/20:4 857·5185
44 859 859·52 36:3 18:1/18:2 859·5342
45 861 861·54 36:2 18:0/18:2 861·5498
46 863 863·56 36:1 18:0/18:1 863·5655
47 865 865·58 36:0 18:0/18:0 865·5811
J (1·2%)
48 871 871·54 e-38:3 a-38:4 a-18:0/20:4 871·5706
49 873 873·56 e-38:2, a-38:3 e-18:1/20:2 873·5862
50 875 875·57 e-38:1, a-38:2 a-18:0/20:2 875·6019
51 877 877·58 e-38:0, a-38:1 e-18:1/20:0 877·6175
52 879 879·60 a-38:0 a-18:0/20:0 879·6332
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Table S7. (Cont.)
Peaka m/z HR m/zb
Lipid
componentc
Principal
componentd Theor m/ze
K (5·3%)
53 879 879·54 38:7 16:1/22:6 879·5029
54 881 881·55 38:6 18:2/20:4 881·5185
55 883 883·57 38:5 18:1/20:4 883·5342
56 885 885·58 38:4 18:0/20:4 885·5498
57 887 887·59 38:3 18:1/20:2 887·5655
58 889 889·60 38:2 18:0/20:2 889·5811
59 891 891·63 38:1 18:0/20:1 891·5968
60 893 893·64 38:0 18:0/20:0 893·6124
L (0·5%)
61 893 893·54 e-40:6 e-18:1/22:6 893·5549
62 895 895·54 e-40:5, a-40:6 a-18:0/22:6 895·5706
63 897 897·56 e-40:4, a-40:5 e-18:1/22:4 897·5862
64 899 899·59 e-40:3, a-40:4 a-18:0/22:4 899·6019
65 901 901·58 e-40:2, a-40:3 e-18:1/22:2 901·6175
66 903 903·61 a-40:2 a-18:0/22:2 903·6332
M (17·8%)
67 903 903·49 40:9 20:4/20:5 903·5029
68 905 905·53 40:8 18:2/22:6 905·5185
69 907 907·55 40:7 20:2/22:5 907·5342
70 909 909·56 40:6 18:0/22:6 909·5498
71 911 911·57 40:5 18:1/22:5 911·5655
72 913 915·58 40:4 18:0/22:4 913·5811
73 915 915·60 40:3 18:1/22:2 915·5968
74 917 917·63 40:2 18:0/22:2 917·6124
75 919 919·66 40:1 18:1/22:0 919·6281
N (0·9%)
76 927 929·54 42:11 20:5/22:6 927·5029
77 929 929·56 42:10 20:4/22:6 929·5185
78 931 931·56 42:9 20:5/22:4 931·5342
79 933 933·57 42:8 20:2/22:6 933·5498
80 935 935·57 42:7 20:5/22:2 935·5655
81 937 937·58 42:6 20:4/22:2 937·5811
82 939 939·63 42:5 18:1/24:4 939·5968
83 941 941·65 42:4 18:0/24:4 941·6124
O (0·7%)
84 953 953·55 44:12 22:6/22:6 953·5185
85 955 955·56 44:11 20:6/24:5 955·5340
86 957 957·57 44:10 22:4/22:6 957·5498
87 959 959·58 44:9 22:4/22:5 959·5654
88 961 961·63 44:8 22:4/22:4 961·5811
89 963 963·64 44:7 20:2/24:5 963·5968
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 8A. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PI species are in bold.
b As in Table S3.
c As in Table S1.
d As in Table S3.
e As in Table S1.
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Table S8. Mass spectrometry analysis of PI molecular species in bloodstream T. brucei
Peak m/za HR m/zb Lipidc
Principal
componentd Theor m/ze
G (0·8%)
1 829 829·49 34:4 14:0/20:4 829·4872
2 831 831·54 34:3 16:1/18:2 831·5029
3 833 833·48 34:2 16:0/18:2 833·5185
4 835 835·53 34:1 16:0/18:1 835·5342
5 837 837·52 34:0 16:0/18:0 837·5498
H (0·8%)
6 843 843·56 e-36:3, a-36:4 a-16:0/20:4 843·5393
7 845 845·53 e-36:2, a-36:3 e-18:1/18:2 845·5549
8 847 847·56 e-36:1, a-36:2 a-18:0/18:2 847·5706
9 849 849·51 e-36:0, a-36:1 a-18:0/18:1 849·5862
10 851 851·54 a-36:0 a-18:0/18:0 851·6019
I (26·8%)
11 857 857·55 36:4 16:0/20:4 857·5185
12 859 859·54 36:3 18:1/18:2 859·5342
13 861 861·52 36:2 18:0/18:2 861·5498
14 863 863·55 36:1 18:0/18:1 863·5655
15 865 865·58 36:0 18:0/18:0 865·5811
J (0·5%)
16 871 871·55 e-38:3 a-38:4 a-18:0/20:4 871·5706
17 873 873·55 e-38:2, a-38:3 e-18:1/20:2 873·5862
18 875 875·54 e-38:1, a-38:2 a-18:0/20:2 875·6019
19 877 877·54 e-38:0, a-38:1 e-18:1/20:0 877·6175
20 879 879·59 a-38:0 a-18:0/20:0 879·6332
K (4·2%)
21 879 879·52 38:7 16:1/22:6 879·5029
22 881 881·54 38:6 18:2/20:4 881·5185
23 883 883·55 38:5 18:1/20:4 883·5342
24 885 885·55 38:4 18:0/20:4 885·5498
25 887 887·58 38:3 18:1/20:2 887·5655
26 889 889·56 38:2 18:0/20:2 889·5811
27 891 891·54 38:1 18:0/20:1 891·5968
28 893 893·59 38:0 18:0/20:0 893·6124
L (1·0%)
29 893 893·54 e-40:6 e-18:1/22:6 893·5549
30 895 895·54 e-40:5, a-40:6 a-18:0/22:6 895·5706
31 897 897·56 e-40:4, a-40:5 e-18:1/22:4 897·5862
32 899 899·59 e-40:3, a-40:4 a-18:0/22:4 899·6019
33 901 901·58 e-40:2, a-40:3 e-18:1/22:2 901·6175
34 903 903·61 a-40:2 a-18:0/22:2 903·6332
M (63·1%)
35 903 903·48 40:9 20:4/20:5 903·5029
36 905 905·50 40:8 18:2/22:6 905·5185
37 907 907·52 40:7 20:2/22:5 907·5342
38 909 909·54 40:6 18:0/22:6 909·5498
39 911 911·54 40:5 18:1/22:5 911·5655
40 913 915·58 40:4 18:0/22:4 913·5811
41 915 915·59 40:3 18:1/22:2 915·5968
42 917 917·60 40:2 18:0/22:2 917·6124
43 919 919·56 40:1 18:1/22:0 919·6281
N (1·3%)
44 927 929·49 42:11 20:5/22:6 927·5029
45 929 929·54 42:10 20:4/22:6 929·5185
46 931 931·58 42:9 20:5/22:4 931·5342
47 933 933·53 42:8 20:2/22:6 933·5498
48 935 935·56 42:7 20:5/22:2 935·5655
49 937 937·59 42:6 20:4/22:2 937·5811
50 939 939·61 42:5 18:1/24:4 939·5968
51 941 941·67 42:4 18:0/24:4 941·6124
O (1·6%)
52 953 953·52 44:12 22:6/22:6 953·5185
53 955 955·54 44:11 20:6/24:5 955·5340
54 957 957·56 44:10 22:4/22:6 957·5498
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Table S8. (Cont.)
Peak m/za HR m/zb Lipidc
Principal
componentd Theor m/ze
55 959 959·58 44:9 22:4/22:5 959·5654
56 961 961·61 44:8 22:4/22:4 961·5811
57 963 963·63 44:7 20:2/24:5 963·5968
a All of the molecular species detected within a series are grouped by a letter are contained within the lowest and highest
mass range and refers to the corresponding peaks in Fig. 8B. The percentages in parentheses correspond to the relative
percentage based upon TIC. The peaks containing the most abundant PI species are in bold.
b As in Table S3.
c As in Table S1.
d As in Table S3.
e As in Table S1.
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Fig. S1. ESI-MS-MS positive ion spectra of choline-containing PLs in T. brucei. Precursor ion scanning for
m/z 184 speciﬁcally detected [M+H]+ PC and SM ions from PCF (A) and BSF (B) trypanosome total lipid
extracts. Peaks are plotted as their relative percent intensity (%) of the largest peak in the spectrum, and as a
function of their mass/charge values (m/z). Peak assignments are based on MS-MS daughter ion spectra
performed as stated in Material and Methods, and each peak series is annotated by a letter, which are
annotated in Tables S1 and S2.
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Fig. S2. ESI-MS-MS positive ion spectra of lyso-PC in T. brucei. Precursor ion scanning for m/z 184
speciﬁcally detected [M+H]+ lyso-PC ions from BSF (A) and PCF (B) trypanosome total lipid extracts.
Peaks are plotted as their relative percent intensity (%) of the largest peak in the spectrum, and as a function
of their mass/charge values (m/z). The major lyso-PC signals were annotated based on their m/z value and
MS-MS daughter ion spectra performed as stated in Material and Methods, and each peak series is
annotated by a letter, which are annotated in Tables S1 and S2.
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Fig. S3. ESI-MS-MS negative ion spectra of PE in T. brucei. Precursor ion scanning for m/z 196
speciﬁcally detected [M−H]− PE ions from PCF (A) and BSF (B) trypanosome total lipid extracts. Peaks
are plotted as their relative percent intensity (%) of the largest peak in the spectrum, and as a function of
their mass/charge values (m/z). Peak assignments are based on MS-MS daughter ion spectra performed as
stated in the Material and Methods, and each peak series is annotated by a letter, which are annotated in
Tables S3 and S4.
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Fig. S4. ESI-MS-MS negative ion spectra of PS in T. brucei. Neutral loss scanning for m/z 87 speciﬁcally
detected [M−H]− PS ions from PCF (A) and BSF (B) trypanosome total lipid extracts. Peaks are plotted as
their relative percent intensity (%) of the largest peak in the spectrum, and as a function of their mass/charge
values (m/z). Peak assignments are based on MS-MS daughter ion spectra performed as stated in Material
and Methods, and each peak series is annotated by a letter, which are annotated in Tables S5 and S6.
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Fig. S5. ESI-MS-MS negative ion spectra of inositol-containing PLs in T. brucei. Precursor ion scanning
for m/z 241 speciﬁcally detected [M−H]− PI and IPC ions from PCF (A) and BSF (B) trypanosome total
lipid extracts. Peaks are plotted as their relative percent intensity (%) of the largest peak in the spectrum, and
as a function of their mass/charge values (m/z). Peak assignments are based on MS-MS daughter ion spectra
performed as stated in Material and Methods, and each peak series is annotated by a letter, which are
annotated in Tables S7 and S8.
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Fig. S6. ESI-MS-MS negative ion spectra revealing PA and PG molecular species in T. brucei. Precursor
ion scanning for m/z 153 in negative ion mode with a collision oﬀset energy of 50 V speciﬁcally detected
[M−H]− ions from glycerophospholipids in a total lipid extract from PCF (A) and BSF (B) trypanosome
total lipid extracts. (upper panel). Peaks are plotted as their relative percent intensity (%) of the largest peak
in the spectrum, and as a function of their mass/charge values (m/z). Fatty acid assignments are based on the
most intense fatty acid signals in the MS-MS daughter ion spectra (lower panel). Saturated fatty acids were
assumed to be in the sn-1 position. Peaks labeled with a letter refer to the peak series that describes it in
previous ﬁgures, to which the number in parentheses refers. Since each class of PL is detected with diﬀerent
optimal oﬀset collision eﬃciencies, the PL class peaks in this spectrum do not accurately represent their true
abundance in the cell relative to other PL classes. e=alkenyl; a=alkyl.
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